MTNB 8-K 2026-09-16

Matinas BioPharma Holdings, Inc. (MTNB) 8-K dated 2026-09-16 — accession 0001493152-26-042954. This URL is the filing, not the MTNB hub.

Matinas BioPharma Holdings, Inc. (MTNB) is a biotechnology company listed on US.

Matinas BioPharma Holdings, Inc. filed a 8-K on 2026-09-16. Accession 0001493152-26-042954.

Cached items: 8.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported MTNB revenue for 2023-09-30 was $1.1M. Net income was -$6.1M. Revenue was up 0.0% from 2023-06-30 to 2023-09-30. MTNB currently screens at market cap $5.6M.

Not investment advice. The MTNB SEC hub lists recent forms. The stock page is the research view.